Tripartite is an international colorectal meeting of surgeons from across Europe, Australasia and the Americas.
Here we presented the colorectal-specific findings of STARSurg's first national collaborative cohort study, assesing the safety profile of NSAIDs in colorectal resection.
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
STARSurg, Tripartite Colorectal Conference, July 2014
1. Multicentre, propensity-matched, cohort
study assessing early post-operative NSAIDs
and adverse events following colorectal
surgery
James Glasbey
on behalf of the STARSurg Collaborative
Final Year Medical Student, Cardiff University
2. Background
• Optimal analgesic regime post-GI surgery has not yet been
determined
• NSAIDs are used as part of ERAS &WHO pain ladder
• NSAIDs have been associated with increased operation-
specific complications, including anastomotic leak (Klein
M, BMJ, 2012;345:e6166)
3. • Prospective, multicentre observational cohort study
• Delivered by a student-driven research collaboration with
a dedicated study protocol
Study Design
4. Methods
• Inclusion: Adults, consecutive elective or emergency, partial
or complete gastrointestinal resections over a 2-week
period
(September – October 2013)
• Primary outcome: 30-day Clavien-Dindo complication
rate
5. Clavien Dindo
I – deviation from standard post-op course within
‘allowed therapeutic regimes’
II – complication req. pharmacological intervention
III – complication req. surgical, endoscopic or radiological
intervention
IV – complication req. ICU admission
V – death
MinorMajor
6. Methods
• Power calculation (80%, n = 900)
• Propensity-score matching
• Multivariate binary logistic regression - odds ratios (OR) &
95% C.I.
• Data validation
13. Limitations
• Narrow time window for data collection
• Risk of selection bias
• Large, pragmatic real-world population with high external
validity
• Risk-adjusted
• 98% accuracy in validated data points
14. Key Messages
• Early NSAID use was associated with reduction in total
complications following colorectal resection
• No evident increase in anastomotic leak (underpowered)
• The student-led, collaborative model can rapidly deliver
high-quality, multi-centre datasets
Good morning, my name is James Glasbey and I’m presenting on behalf of the STARSurg Collaborative. My talk is on our first project, titled; Multi-centre, propensity-match, cohort study assessing early post operative NSAIDs and adverse events following GI surgery.
As a background, the ideal analgesic regime following GI surgery has not yet been determined.
NSAIDS are used routinely as part of ERAS and the lower echelons WHO pain ladder. As Professor Lobo alluded to in his intestinal failure lecture yesterday hey have the advantage of being opiate sparing, enhancing return of bowel function and therefore expediting recovery.
However, literature shows NSAIDs being associated with increased complications, including anastomotic leak.
The study design was a prospective, multicentre observation cohort study
This project was delivered by the student-led research group starsurg, which recruited 253 medical students and junior doctors from 31 UK medical school across the UK with consultant oversight, with local investigators responsible for approving the study with governance offices and ensuirng data quality
Inclusion criteria for this study was all consecutive elective and emergency GI resections over a 2 week during september and october 2013
Our primary outcome was a 30 day Clavien-Dindo complication rate.
Briefly …
I – antipyretics, duiretics, electrolytes
We developed an online teaching module to familarise collaborators with this measure.
The primary endpoint was powered to 80% to detect a 10% increase in clavien-dindo complicate rate, which required us to recruit 900 patients.
The data was propensity matched to risk adjust to ASA grades and a revised cardiac risk index
We then used a multivariate binary logistic regression model to generate odds ratios with bootstrapped 95% CI
Finally, we prospectively-considered external data validation, with independent assessors recollecting 5% of data points to assess accuracy
As was seen with Kleins 2012 paper0
76% of the resections were colorectal
In terms of anti-inflammatory prescribing, 18.9% of patients where prescribed early NSAIDs, which was more likely for those patients on an ERAS programme
The majority were prescribed ibuprofen
62% of patients had complications, which were major in 17% and minor in 45%
Anastomotic leak rate of 4.9% comparable to a dutch cohort published in the BJS this year
So to our regression model
Regarding the effects of any dose NSAIDs, they were counterintuitvely associated with a reduction of all complications.
This was scene more prominently in the high-dose NSAID compared to low dose
And was seen in minor complications but not major (IV & V)
Selection bias as more well patients may have put onto ERAS programmes and avoided opioid therpies
The improved odds ratios remaining despite risk-adjustment
And data points were validated to a high degree of accuracy
This leaves me with 3 key messages:
Early NSAID use was associated with a reduction in post-operative adverse events following GI resection, indicating a beneficial anti-inflammatory effect – note in terms of NSAIDs were are predominantly talking about ibuprofen, which in fact was also demonstrated to be safe in kleins BMJ paper also. This has relevance to future perioperative analgesic prescribing and we think justifies further exploration
No evident increase in anastomotic leak with early NSAID use and although this is probably underpowered, ibuprofen is probably safe in low to mdeium risk patients, perhaps even high risk if given as one off or short course
3. The student-led, collaborative model can rapidly deliver high-quality multicentre dataset and we are excited to expand this over coming years.